Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001731122-23-001993
Filing Date
2023-10-30
Accepted
2023-10-30 09:15:24
Documents
7
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A e5171_10-ka.htm 10-K/A 227338
2 EXHIBIT 10.12 e5171_ex10-12.htm EX-10.12 231253
3 EXHIBIT 21.1 e5171_ex21-1.htm EX-21.1 3127
4 EXHIBIT 31.1 e5171_ex31-1.htm EX-31.1 9458
5 EXHIBIT 31.2 e5171_ex31-2.htm EX-31.2 9275
6 EXHIBIT 32.1 e5171_ex32-1.htm EX-32.1 5421
7 EXHIBIT 32.2 e5171_ex32-2.htm EX-32.2 4751
  Complete submission text file 0001731122-23-001993.txt   492018
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-38758 | Film No.: 231357709
SIC: 2834 Pharmaceutical Preparations